Malvika Gulati
@mgulati.bsky.social
Clinical Research Fellow
@VersusArthritis
| Rheumatology Registrar | #Osteoarthritis |
@uniofOxford
Clarendon Scholar
@Clarendon_OU
| mum of two :-)
@VersusArthritis
| Rheumatology Registrar | #Osteoarthritis |
@uniofOxford
Clarendon Scholar
@Clarendon_OU
| mum of two :-)
Reposted by Malvika Gulati
Dr. Kennedy Amaral from Brazil on Chikungunya & rheumatology
Basics:
🦠RNA virus, Alphavirus genus
🦟Mosquito vector - Aedes aegypti & albopictus
🦵100% have arthralgia but some don't have fever
#ACR24
Basics:
🦠RNA virus, Alphavirus genus
🦟Mosquito vector - Aedes aegypti & albopictus
🦵100% have arthralgia but some don't have fever
#ACR24
November 14, 2024 at 4:53 PM
Dr. Kennedy Amaral from Brazil on Chikungunya & rheumatology
Basics:
🦠RNA virus, Alphavirus genus
🦟Mosquito vector - Aedes aegypti & albopictus
🦵100% have arthralgia but some don't have fever
#ACR24
Basics:
🦠RNA virus, Alphavirus genus
🦟Mosquito vector - Aedes aegypti & albopictus
🦵100% have arthralgia but some don't have fever
#ACR24
Reposted by Malvika Gulati
#ACR24 Lupus Nephritis CARE
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
November 18, 2024 at 1:27 PM
#ACR24 Lupus Nephritis CARE
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
• By Dr. Maria Dall'Era (UCSF)
Review of #LupusNephritis 🫘
▪️Rx TRIPLE therapy
▪️belimumab vs voclosporin
▪️low level proteinuria (even *UPCR <0.5*) can STILL be associated with disease activity (Class III/IV/V)
#Lupus #RheumSky #NephSky
Reposted by Malvika Gulati
Clinical Year in Review at #ACR24
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
November 17, 2024 at 2:40 PM
Clinical Year in Review at #ACR24
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky
Presented by Dr. Michael Pillinger
• Review some of the most impactful studies in Rheumatology from the past year!
#MedSky #Rheumatology #RheumSky